Hospital or health organisation · founded 1876
The University of Texas MD Anderson Cancer Center
Houston, United States · mdanderson.org
- Citations, last 5 years
- 470.2k
- Works, last 5 years
- 44.3k
- h-index
- 1,800
- Scientists listed
- 5 302
- Grants since 2016
- 2 323
Grants received
2017–2022 · research · R01
Fasting Protects Small Intestinal Stem Cells from Lethal DNA Damage: Mechanistic Insight and Preclinical Translation
Helen M Piwnica-Worms · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · research · R37
Role of Quaking gene in regulating the niche-independent stemness of glioma stem cells
Jian Hu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Preclinical characterization of EMT/CSC-specific small molecule inhibitors for TNBCs
Luke Lee Lairson · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Inhibition of brain metastasis by blocking MAPK12 driver kinase functions
Dihua Yu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · cooperative agreement · U01
Enhancing Chemoradiation Efficacy through Unbiased Drug Discovery Approaches
Sunil Krishnan · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2023 · research · R01
53BP1-dependent pathway in DNA repair
Junjie Chen · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2020 · research · R01
imaging Radiation-Associated Dysphagia (iRAD)
Clifton David Fuller · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017 · grant · Academic Research
Identification of Critical Dependencies and Actionable Therapeutic Options in Smarcb1-Deficient Pediatric Tumors
Giulio F Draetta · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2017–2022 · cooperative agreement · U24
Pancreatic Ductal Adenocarcinoma Translational Resource Center (PATReC)
Anirban Maitra · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2024 · research · R01
Molecular Mechanisms Underlying Environmental Effects that Influence Penetrance in Lynch Syndrome-Associated Endometrial Cancer
Melinda S. Yates · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2023 · cooperative agreement · U24
Translational Cancer Immune Monitoring and Analysis Center (TCIMAC)
Gheath Al-Atrash · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017 · prize · Warren Alpert Foundation Prize
Warren Alpert Foundation Prize 2017 - James Allison
James Allison · The University of Texas MD Anderson Cancer Center · funded by Warren Alpert Foundation
2017–2022 · cooperative agreement · U01
Development of Risk and Early Detection Biomarker for Small Cell Lung Cancer
Samir M Hanash · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017 · grant · Academic Research
Novel Regulation and Function of TAK1 in Mutant Kras-driven Development of Pancreatic Ductal Adenocarcinoma
Paul Chiao · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2017–2021 · program · P20
2/2 U-HAND (University of Houston/MD Anderson) Program to Reduce Cancer Disparities
Lorna H. Mcneill · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2019 · contract · N01
IGF::OT::IGF DETERMINATION OF DOSING REGIMENS OF ERLOTINIB IN COMBINATION WITH SULINDAC FOR PREVENTION OF COLORECTAL CANCER WHILE REDUCING AGENT TOXICITY POP 06/01/2017 - 05/31/2019
Powel Brown · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Multi-Site Development & Evaluation of a Quantitative 3D Hyperpolarized C-13 MRI Clinical Prostate Cancer Exam
James A Bankson · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2021 · research · R01
Role of response regulator phosphorylation in group A streptococcal pathogenesis
Samuel A Shelburne · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Role of the Histone Modifier KDM2A in Lung Cancer
Min Gyu Lee · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · research · R25
Scientific Communication Advances Research Excellence (SCOARE)
Carrie A. Cameron · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Uncovering the Role of Colorectal Stem Cells on Disease Penetrance in Lynch Syndrome
Eduardo Vilar Sanchez · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · program · P40
Specific Pathogen Free Baboon Research Resource (SPFBRR)
Joe H. Simmons · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2021 · grant · Continuing Grant
Collaborative Research: Impacts of social context and ecology on strategic decisions in dynamic interactions
Steven Schapiro · The University of Texas MD Anderson Cancer Center · funded by National Science Foundation
2017–2018 · research · R37
Synthesizing Image-derived Heterogeneity with Genomic measurements for Assessing Disease Aggressiveness in Lower Grade Gliomas
Sebastian Kurtek · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · cooperative agreement · U01
Integrating Biospecimen Science Into The Development Of RNA-Based Clinical Assays For Patients With Metastatic Breast Cancer
William F Symmans · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · research · R25
Scientific Communication Advances Research Excellence (SCOARE)
Carrie A. Cameron · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2023 · program · P40
Specific Pathogen Free Baboon Research Resource (SPFBRR) - A&R Administrative Supplement
Joe H. Simmons · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
BET protein antagonist-based targeted therapy of Mantle Cell Lymphoma
Kapil Bhalla · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2028 · program · P40
Specific Pathogen Free 18 Baboon Research Resource (SPF18BRR)
William D Hopkins · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · cooperative agreement · U01
Integrative bioinformatics and functional characterization of oncogenic driver aberrations in cancer
Gordon B. Mills · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017 · grant · Academic Research
The University of Texas M.D. Anderson Cancer Center Science Park Flow Cytometry and Cell Imaging Core
Ellen Richie · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2017–2019 · cooperative agreement · U54
University of Texas PDX Development and Trial Center
Funda Meric-Bernstam · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2023 · research · R01
Role of the Histone Modifier KDM2A in Lung Cancer
Min Gyu Lee · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2019 · research · R21
Inhibition of Stromal-Derived DKK3 to Enhance the Response of Pancreatic Cancer to Immunotherapy
Rosa F. Hwang · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017 · grant · Academic Research
Capitalizing on Therapeutic Liabilities in RAS-Mutant Cancers With a Rational Combination Therapy With PARP and MEK Inhibitors
Anil Korkut · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2017–2022 · research · R01
Signaling Mechanisms of Opioid-Induced Hyperalgesia and Tolerance
Hui-Lin Pan · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · cooperative agreement · U54
University of Texas PDX Development and Trial Center
Funda Meric-Bernstam · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2019 · career development · K99
Breast Cancer Screening: Priorities and Attitudes of Diverse Women Under 50
Ashley Housten · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · research · R50
Functional Proteomics by Reverse Phase Protein Array in Cancer
Yiling Lu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2019 · award
Track and target chemoresistant subclones in triple negative breast cancer
Gloria Echeverria · The University of Texas MD Anderson Cancer Center · funded by American Cancer Society
